A German Drugmaker (Boehringer Ingelheim) accidently stumbled upon what could be the next Viagra-For-Women when working on an anti-depressant drug (what a coincidence). The company used clinical trials just like any other pharm looking to develop an anti-depressant. During clinical trials, female participants noticed a “sudden surge” in sexual arousal. Doctors investigating new treatments for women retort that men’s problems were also seen as largely psychological until Viagra came along, and that loss of sexual desire isn’t trivial to many of those who experience it.

Indeed, Boehringer says it’s having no trouble recruiting women for the trial, some of whom travel long distances for the chance to try the drug. Even if flibanserin doesn’t pan out, understanding how it boosts desire should point the way to better versions—and perhaps give women a choice about whether or not to pop a little pill.